U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C35H38N6O6
Molecular Weight 638.7128
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-Cilexetil Candesartan Ethyl Ester

SMILES

CCOC(=O)C1=CC=CC2=C1N(CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5C(C)OC(=O)OC6CCCCC6)C(OCC)=N2

InChI

InChIKey=SJAVCSABPBKRNM-UHFFFAOYSA-N
InChI=1S/C35H38N6O6/c1-4-44-33(42)29-16-11-17-30-31(29)40(34(36-30)45-5-2)22-24-18-20-25(21-19-24)27-14-9-10-15-28(27)32-37-38-39-41(32)23(3)46-35(43)47-26-12-7-6-8-13-26/h9-11,14-21,23,26H,4-8,12-13,22H2,1-3H3

HIDE SMILES / InChI

Approval Year

Name Type Language
1H-Benzimidazole-7-carboxylic acid, 1-[[2?-[1-[1-[[(cyclohexyloxy)carbonyl]oxy]ethyl]-1H-tetrazol-5-yl][1,1?-biphenyl]-4-yl]methyl]-2-ethoxy-, ethyl ester
Preferred Name English
N-Cilexetil Candesartan Ethyl Ester
Systematic Name English
Ethyl 1-[[2?-[1-[1-[[(cyclohexyloxy)carbonyl]oxy]ethyl]-1H-tetrazol-5-yl][1,1?-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
Systematic Name English
Code System Code Type Description
CAS
1391054-45-7
Created by admin on Wed Apr 02 17:10:08 GMT 2025 , Edited by admin on Wed Apr 02 17:10:08 GMT 2025
PRIMARY
FDA UNII
4AGW6XQX7N
Created by admin on Wed Apr 02 17:10:08 GMT 2025 , Edited by admin on Wed Apr 02 17:10:08 GMT 2025
PRIMARY
PUBCHEM
71314866
Created by admin on Wed Apr 02 17:10:08 GMT 2025 , Edited by admin on Wed Apr 02 17:10:08 GMT 2025
PRIMARY